The company supplied its COVID vaccines to the EU during the pandemic, but the contract for its Omicron-adjusted vaccines ended in August last year and was not renewed. "Moderna manufactured its updated COVID-19 vaccine at risk to ensure we could support member states with their upcoming vaccination campaigns," a company spokesperson said, adding the updated shot was approved in Europe and ready to be supplied. Updated COVID shots that will be used in the vaccination campaign this year will target the XBB.1.5 variant of Omicron.